| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A love letter for my father
|
De Ambrogi, Marco
|
|
|
20 |
4 |
p. 424
|
article
|
| 2 |
Are placebo controls necessary in controlled human infection trials for vaccines?
|
Langenberg, Marijke C C
|
|
|
20 |
4 |
p. e69-e74
|
article
|
| 3 |
Asymptomatic cases in a family cluster with SARS-CoV-2 infection
|
Pan, Xingfei
|
|
|
20 |
4 |
p. 410-411
|
article
|
| 4 |
A trial for post-exposure prophylaxis against henipaviruses
|
Sazzad, Hossain M S
|
|
|
20 |
4 |
p. 387-388
|
article
|
| 5 |
A vaccine for meningococcal B disease and gonorrhoea
|
Kirby, Tony
|
|
|
20 |
4 |
p. 417
|
article
|
| 6 |
Convalescent plasma as a potential therapy for COVID-19
|
Chen, Long
|
|
|
20 |
4 |
p. 398-400
|
article
|
| 7 |
Correction to Lancet Infect Dis 2019; 19: 903–12
|
|
|
|
20 |
4 |
p. e50
|
article
|
| 8 |
Correction to Lancet Infect Dis 2020; 20: 259
|
|
|
|
20 |
4 |
p. e50
|
article
|
| 9 |
Correction to Lancet Infect Dis 2020; published online Feb 18. https://doi.org/10.1016/S1473-3099(20)30111-0
|
|
|
|
20 |
4 |
p. e50
|
article
|
| 10 |
Correction to Lancet Infect Dis 2020; published online Feb 11. https://doi.org/10.1016/S1473-3099(20)30003-7
|
|
|
|
20 |
4 |
p. e50
|
article
|
| 11 |
COVID-19, a pandemic or not?
|
The Lancet Infectious Diseases,
|
|
|
20 |
4 |
p. 383
|
article
|
| 12 |
COVID-19: combining antiviral and anti-inflammatory treatments
|
Stebbing, Justin
|
|
|
20 |
4 |
p. 400-402
|
article
|
| 13 |
COVID-19 pneumonia: what has CT taught us?
|
Lee, Elaine Y P
|
|
|
20 |
4 |
p. 384-385
|
article
|
| 14 |
COVID-19 with spontaneous pneumomediastinum
|
Zhou, Changyu
|
|
|
20 |
4 |
p. 510
|
article
|
| 15 |
Dolutegravir and neural tube defects: a new insight
|
Chouchana, Laurent
|
|
|
20 |
4 |
p. 405-406
|
article
|
| 16 |
Ebola virus disease in DR Congo
|
Burki, Talha
|
|
|
20 |
4 |
p. 418-419
|
article
|
| 17 |
Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study
|
Liebowitz, David
|
|
|
20 |
4 |
p. 435-444
|
article
|
| 18 |
Extended-spectrum β-lactamase-producing Escherichia coli
|
Huang, Ying
|
|
|
20 |
4 |
p. 404-405
|
article
|
| 19 |
Extended-spectrum β-lactamase-producing Escherichia coli
|
Sloth, Louise B
|
|
|
20 |
4 |
p. 405
|
article
|
| 20 |
Fighting malaria with ivermectin: a novel malaria control tool
|
Teboh-Ewungkem, Miranda I
|
|
|
20 |
4 |
p. 394-395
|
article
|
| 21 |
Francis (Frank) Allan Plummer
|
Venkatesan, Priya
|
|
|
20 |
4 |
p. 421
|
article
|
| 22 |
From boat racing to the love of leprosy elimination
|
Balakrishnan, Vijay Shankar
|
|
|
20 |
4 |
p. 423
|
article
|
| 23 |
Getting to zero in the DR Congo Ebola outbreak
|
Dhillon, Ranu S
|
|
|
20 |
4 |
p. 395-397
|
article
|
| 24 |
Helen Marshall
|
Kirby, Tony
|
|
|
20 |
4 |
p. 422
|
article
|
| 25 |
HTLV-1 infection and health outcomes
|
Song, Minkyo
|
|
|
20 |
4 |
p. 406-407
|
article
|
| 26 |
HTLV-1 infection and health outcomes
|
Ramos, José-Manuel
|
|
|
20 |
4 |
p. 407-408
|
article
|
| 27 |
Hydromorphone and the risk of infective endocarditis among people who inject drugs: a population-based, retrospective cohort study
|
Silverman, Michael
|
|
|
20 |
4 |
p. 487-497
|
article
|
| 28 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
20 |
4 |
p. 419
|
article
|
| 29 |
Initiation of a new infection control system for the COVID-19 outbreak
|
Chen, Xuejiao
|
|
|
20 |
4 |
p. 397-398
|
article
|
| 30 |
Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study
|
Slater, Hannah C
|
|
|
20 |
4 |
p. 498-508
|
article
|
| 31 |
Linking prescription opioids and infectious diseases
|
Schranz, Asher J
|
|
|
20 |
4 |
p. 392-394
|
article
|
| 32 |
Madagascar's vulnerable children
|
Bagcchi, Sanjeet
|
|
|
20 |
4 |
p. 416
|
article
|
| 33 |
Measles vaccination in infants younger than 9 months
|
de Gier, Brechje
|
|
|
20 |
4 |
p. 403
|
article
|
| 34 |
New guidelines for latent tuberculosis
|
Mushtaq, Ammara
|
|
|
20 |
4 |
p. 414
|
article
|
| 35 |
Oral influenza vaccination—a possible solution for the next pandemic?
|
Rudenko, Larisa
|
|
|
20 |
4 |
p. 385-386
|
article
|
| 36 |
Phylogenomic analysis of Neisseria gonorrhoeae: a promising tool for tracking putative gonococcal sexual networks
|
Jolly, Ann M
|
|
|
20 |
4 |
p. 391-392
|
article
|
| 37 |
Phylogenomic analysis of Neisseria gonorrhoeae transmission to assess sexual mixing and HIV transmission risk in England: a cross-sectional, observational, whole-genome sequencing study
|
Town, Katy
|
|
|
20 |
4 |
p. 478-486
|
article
|
| 38 |
Primary tuberculosis of the glans penis in an immunocompetent male
|
Banerji, John S
|
|
|
20 |
4 |
p. 509
|
article
|
| 39 |
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
|
Shi, Heshui
|
|
|
20 |
4 |
p. 425-434
|
article
|
| 40 |
Relaunching human bornavirus research from encephalitis cases with unclear cause
|
Honda, Tomoyuki
|
|
|
20 |
4 |
p. 389-391
|
article
|
| 41 |
Research brief
|
Mohammadi, Dara
|
|
|
20 |
4 |
p. 420
|
article
|
| 42 |
Researching Zika in pregnancy: lessons for global preparedness
|
Ades, A E
|
|
|
20 |
4 |
p. e61-e68
|
article
|
| 43 |
Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial
|
Clarke, David K
|
|
|
20 |
4 |
p. 455-466
|
article
|
| 44 |
Safety and immunogenicity of vesicular stomatitis virus-based vaccines for Ebola virus disease
|
de La Vega, Marc-Antoine
|
|
|
20 |
4 |
p. 388-389
|
article
|
| 45 |
Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study
|
Playford, Elliott Geoffrey
|
|
|
20 |
4 |
p. 445-454
|
article
|
| 46 |
Scrutinising Lyme disease in the UK
|
Cairns, Victoria
|
|
|
20 |
4 |
p. 403-404
|
article
|
| 47 |
The first Vietnamese case of COVID-19 acquired from China
|
Van Cuong, Le
|
|
|
20 |
4 |
p. 408-409
|
article
|
| 48 |
The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later
|
Laxminarayan, Ramanan
|
|
|
20 |
4 |
p. e51-e60
|
article
|
| 49 |
The 7th London Centre for NTDs conference
|
York, Alexandra
|
|
|
20 |
4 |
p. 413
|
article
|
| 50 |
US public health budget cuts in the face of COVID-19
|
Devi, Sharmila
|
|
|
20 |
4 |
p. 415
|
article
|
| 51 |
Viral load of SARS-CoV-2 in clinical samples
|
Pan, Yang
|
|
|
20 |
4 |
p. 411-412
|
article
|
| 52 |
Why we should stop using the word leprosy
|
Deps, Patrícia
|
|
|
20 |
4 |
p. e75-e78
|
article
|
| 53 |
Zoonotic spillover infections with Borna disease virus 1 leading to fatal human encephalitis, 1999–2019: an epidemiological investigation
|
Niller, Hans Helmut
|
|
|
20 |
4 |
p. 467-477
|
article
|
Journal description